Atlas Trials

GI Innovation, Inc.

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch GI Innovation, Inc.

RecordFirmDate
A Study to Evaluate the Effects of the Combination of GI-102 With GIB-7 on Biomarkers of Aging in Healthy Adults and Cancer Survivors (NCT07363057)GI Innovation, Inc.2026-01-01
A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors (NCT07172802)GI Innovation, Inc.2025-04-22
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) (NCT05824975)GI Innovation, Inc.2023-05-30
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors (NCT04977453)GI Innovation, Inc.2021-08-02

Track GI Innovation, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.